Featured Stories
Tennessee Resident Files Pradaxa Bleeding Lawsuit Following Cerebral Hemorrhage

Tennessee Resident Files Pradaxa Bleeding Lawsuit Following Cerebral Hemorrhage

A man from Tennessee has filed a lawsuit against the maker of Pradaxa, claiming that the blood thinner caused him to suffer a cerebral hemorrhage. The complaint alleges Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause Serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects ...

Read More

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...

Read More

Transvaginal Mesh Lawsuit Trial

$5.5 Million Awarded to Plaintiffs in First Transvaginal Mesh Lawsuit Trial

An award of $5.5 million has been made in the first trial over a transvaginal mesh lawsuit. The jury found against medical device maker, C.R. Bard, and its Avaulta Plus transvaginal mesh. The jury agreed that Bard’s Avaulta Plus transvaginal mesh caused numerous and painful injuries in a California woman. ...

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that the risk of atypical thigh fractures increases the longer a ...

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

Newly-Filed Plavix Lawsuits Claim Drug Caused Gastrointestinal Bleeds, Cerebral Hemorrhage, and TTP

Newly-Filed Plavix Lawsuits Claim Drug Caused Gastrointestinal Bleeds, Cerebral Hemorrhage, and TTP

The manufacturer of Plavix continues to be named in lawsuits alleging the blood thinner caused some patients to suffer from serious bleeding side effects. Most recently, the national law firm of Parker Waichman LLP filed nine Plavix bleeding lawsuits in state court in New York.

Read More

Transvaginal Mesh a Nightmare for Thousands of Women

Transvaginal Mesh a Nightmare for Thousands of Women

Thousands of women who have received transvaginal mesh surgical implants to treat stress urinary incontinence (SUI) and pelvic organ prolapse (POP) are now living a nightmare, thanks to debilitating pain, bleeding, infection and other serious complications. According to the Sun-Sentinel, many of the women injured by transvaginal mesh claim ...

Read More

Lawsuit Alleges Plavix Caused Oklahoma Man to Suffer Multiple Stomach Bleeds

Lawsuit Alleges Plavix Caused Oklahoma Man to Suffer Multiple Stomach Bleeds

Another lawsuit has been filed over adverse Plavix side effects. The lawsuit, filed by national law firm Parker Waichman LLP, alleges that the blood thinner, Plavix (clopidogrel), caused an Oklahoma man to suffer from multiple stomach bleeds.

Read More

Motion to Consolidate Xarelto Bleeding Side Effects Cases in Multidistrict Litigation

Xarelto-Bleeding-Side-EffectsPlaintiffs who allege they were injured by the blood thinner Xarelto have filed a motion to have their cases consolidated as part of a multidistrict litigation (MDL).

At least 21 actions pending in 10 judicial districts make similar allegations against the manufacturers of Xarelto (rivaroxaban), a medicine prescribed to prevent or treat blood clots and reduce the risk of stroke. An MDL coordinates proceedings in complex litigation where a large number of lawsuits allege similar injuries associated with a medication or product. The motion requests the U.S. Joint Panel of Multidistrict Litigation (JPML) to assign the MDL to the Southern Illinois District, which handled the recent MDL involving another new anticoagulant, Pradaxa. Continue reading

Posted in Defective Products, Pharmaceuticals, Pradaxa |

Motion Filed to Consolidate Xarelto Lawsuits into MDL

Xarelto_LawsuitsThe anticoagulant Xarelto has raised a number of safety concerns in the short time it has been on the market. A number of lawsuits have been filed alleging that Bayer hid the risks of the drug, including an increased risk of bleeding. Now, a motion has been filed to consolidate the lawsuits into a multidistrict litigation (MDL).

The U.S. Joint Panel of Multidistrict Litigation (JPML) should centralize cases in the Southern District Illinois court, the motion stated. Plaintiffs said that the court is an ideal venue because it has has experience with the recent MDL over Pradaxa, another new bloodthinner. In a hearing that will take place either late this year or early next year, the JPML will hear arguments on the motion. Continue reading

Posted in Legal News |

Toyota Recalls 1.67 Million Vehicles Worldwide

Toyota_Recalls_1.67_Million_VehiclesToyota Motor Corp. has announced the recall of 1.67 million vehicles worldwide over safety defects, including faulty brakes and fuel components.

A Toyota representative said the company is not aware of any accidents or injuries related to the defects. The recall involves 1 million vehicles in Japan and 615,000 in other countries, Law360 reports. Fuel delivery pipe problems affect 759,000 vehicles and 802,000 others have brake issues. In addition, 190,000 Corolla Rumion and Auris models in Japan will be recalled because of faulty emission control components. All of the recalled vehicles in the United States are Lexus sedans with potentially leaky fuel pipes, which could cause the cars to catch fire, the Toyota representative said. Continue reading

Posted in Defective Products, Motor Vehicles, Product Recalls, Recalled Vehicles, Toyota Recall |

Study: Significant Number of Medication Errors Occur in Young Children

Medication-Errors-Occur-in-Young-ChildrenAccording to a study published in the journal Pediatrics, medication mistakes among young children occur more frequently than some would imagine. The study, which was based on calls to poison control hotlines, found that a medication mistake occurred in a child roughly every eight minutes from 2002 through 2012. The authors state that medication mistakes can lead to injury and sometimes death, in addition to increasing healthcare spending.

Researchers saw an increase in the rate of reported medication errors during the 11-year time frame of the study. The exception to this was cough and cold medicines. Henry Spiller, an author of the study and director of the Central Ohio Poison Center at Nationwide Children’s Hospital in Columbus, told Reuters Health that this decrease was preceded by a multipronged campaign to reduce the use of these products in children. The findings suggest that education has been successful in this effort. “We think that multipronged effort had an effect,” said Spiller to Reuters Health. “We can see a drop associated with these efforts.” Continue reading

Posted in Legal News |

New Jersey Appeals Court Considering Facebook Ethics Case

Facebook_Ethics_CaseA New Jersey appeals court is considering whether the Office of Attorney Ethics has the power to file ethics grievances against lawyers after district ethics committees have declined to do so, and whether the judges themselves even have the authority to get involved in the dispute.

If the panel decides that the Superior Courts can exercise jurisdiction over ethics matters, it will then have to decide whether OAE Director Charles Centinaro violated the rules governing the disciplinary process when he filed a complaint against two lawyers in Hackensack, after District II-B Ethics Committee secretary Doris Newman concluded their actions did not constitute unethical conduct, New Jersey Law Journal reports. Continue reading

Posted in Legal News |

Limited Data Available on Medication Dosage for Kids

Medication_Dosage_for_KidsWhen it comes to prescribing medication for children, there is often little data to support information about dosage, safety or efficiency. According to Scientific American, most clinical trials do not include children so the burden of deciding what treatments to use and how falls on physicians.

Scientific American reports that only 46 percent of drugs used in kids have been approved by the U.S. Food and Drug Administration (FDA) for pediatric use. In the past, that statistic was far worse. Continue reading

Posted in Legal News |

Trinity Industries Accused of Hiding Failed Crash Tests in Whistleblower Trial over Guardrails

Trinity_Industries_Accused_of_Hiding_Failed_Crash_TestsIn a trial over its guardrails, Trinity Industries was questioned about why they did not tell authorities about five failed crash tests. The New York Times reports that the case was filed under the False Claims Act by a competitor who alleged that the company violated federal rules when it failed to notify the Federal Highway Administration that it modified the design of its ET-Plus rail head in 2005.

These guardrails are the subject of the safety concerns outside of this federal lawsuits, according to The New York Times. Last month, the states of Missouri and Massachusetts banned the design and began their own investigations. Virginia also took issued with Trinity, and said in a letter that it believes the company failed to adequately test the ET-Plus. The state wants further testing. Continue reading

Posted in Legal News |

Jury Problems Not Enough to Reverse No-Cause Verdict

Jury_Problems_Not_Enough_to_Reverse_No_Cause_VerdictDespite indications that a jury might have misunderstood what evidence it was allowed to consider and that one juror called the plaintiff a liar in a discussion outside the jury room, an appeals court found there were not sufficient grounds to reverse the no-cause verdict.

The appeals court upheld the verdict and the trial judge’s denial of a request for either post-verdict questioning of the jurors or a new trial. The plaintiff had sued over whiplash injuries to her neck allegedly from a 2010 automobile accident, where her car was rear ended and her head slammed into the back of her seat, the New Jersey Law Journal reports. Continue reading

Posted in Accident, Legal News |

Class Action Lawsuit over Infuse Could Complicate Medtronic Acquisition of Covidien

Medtronic-acquires-CovidienA class action lawsuit over Medtronic’s bone growth product Infuse could complicate the company’s planned acquisition of Dublin-based device maker Covidien.

U.S. District Judge John Tunheim will allow lawyers for Medtronic investors to explore an alleged coverup of Infuse’s side effects by Medtronic officials, the Minneapolis Star Tribune reports. Off-label use of Infuse has allegedly injured thousands of patients. Tunheim said the plaintiffs could pursue their claim that former Medtronic CEO William Hawkins purposely made misstatements to stock analysts to hide the fact that the Food and Drug Administration (FDA) had refused to approve Amplify, the next iteration of Infuse. Continue reading

Posted in Class Action Lawsuits, Defective Medical Devices, Legal News, Medtronic Infuse |

Sugary Sodas may be Linked to Higher Risk of Rheumatoid Arthritis

Sugary_Sodas_Linked to_Risk_of_Rheumatoid_ArthritisAccording to a study recently published in The American Journal of Clinical Nutrition, women are more likely to develop rheumatoid arthritis (RA) if they drink one or more sugar-sweetened sodas a day compared those who drink less than one soda per month or less.

According to the Arthritis Today, RA leads to inflammation and subsequent joint pain and damage, fatigue and other consequences. It is a systemic, autoimmune disease believed to be caused by a combination of genetic and environmental factors. Continue reading

Posted in Legal News |

© 2005-2014 Parker Waichman LLP ®. All Rights Reserved.